11/16/2015
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
Dual antiplatelet therapy (DAPT) has become a mainstay in the secondary prevention of cardiovascular (CV) events in patients with a recent history of myocardial infarction (MI) or recent percutaneous...